Close Close

Portfolio > Alternative Investments > Hedge Funds

Mellon HBV Alternatives Expands

Your article was successfully shared with the contacts you provided.

NEW YORK (–Mellon HBV Alternative Strategies recently expanded its staff roster, adding among others a new marketing chief, Charles Poznek.

Mr. Poznek, formerly a hedge fund investor-relations specialist for institutional investors at the New York-based Palladin Group, will report to HBV Mellon Principal Jonathan Bean. The appointment comes only weeks after Mellon completed its acquisition of the London-based HBV Group, (Previous HedgeWorld Story) which was established in 1999 and has seen its assets under management triple to roughly US$530 million over the last 16 months.

In the wake of the Mellon acquisition, other support staffers also were added to the alternative investment team, including a comptroller for the hedge fund group. Prior to the merger, HBV had about 30 staffers.

Mr. Poznek and the other members of the Mellon HBV team will likely have their hands busy. The firm is in the process of putting together new funds, including a global arbitrage fund, expected to be unveiled later this month.

At the time the merger was announced, Mr. Bean said that the deal was driven by the “institutionalization” of the alternative investment arena and that teaming up with Mellon would provide HBV with a distribution platform to reach a wider audience.

He also said Mellon would help develop infrastructure that would make the firm’s single-manager hedge fund strategies more attractive to conservative institutional investors as well as resources to develop new investment strategies.


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.